|
Korean Job Discussion Forums
"The Internet's Meeting Place for ESL/EFL Teachers from Around the World!"
|
| View previous topic :: View next topic |
| Author |
Message |
Octavius Hite
Joined: 28 Jan 2004
Location: Househunting, looking for a new bunker from which to convert the world to homosexuality.
|
 Posted: Sun Aug 27, 2006 8:03 pm Post subject: Eleven-year-old girls 'to get cervical cancer jabs' |
 |
|
This is great news, hopefully the anti-science Americans will follow this lead. But this is one of the reasons I would never want to have a daughter.
http://www.dailymail.co.uk/pages/live/articles/health/healthmain.html?in_article_id=402507&in_page_id=1774
| Quote: |
A cancer research doctor today welcomed a report that health experts are considering a vaccination programme against cervical cancer in primary school children.
The health experts are discussing vaccinating young girls against the human papilloma virus, which is spread by sexual activity and is the major cause of cervical cancer.
Dr Anne Szarewski, clinical consultant for Cancer Research UK, who is working on the trials of one such vaccine, said: "I would be in favour of vaccination at 11 or 12. We know that a significant proportion of girls have sex before the age of consent and it is important to give them protection."
Today's Sunday Telegraph says the Joint Committee on Vaccination and Immunisation (JCVI), a group of experts who advise the Department of Health, may make a recommendation on the issue of vaccination for young girls in October.
Health researchers have been testing parents' attitudes to vaccination including at primary school age, the report says.
Concerns
They have been finding that some parents raise concerns about introducing the vaccine at that age, favouring instead early adolescence at secondary school.
Dr Szarewski took a similar view, saying: "I don't think offering vaccination at 10 would be very successful because parents really do not wish to think their daughters will be sexually active in a few years' time at that age.
"In an ideal world, once we know that the immune protection lasts a long time, then it might be best to give it to toddlers along with the other childhood vaccines, thus removing any connection with sexual activity.
"Since we know that the vaccines work up to five years, giving it at 11 or 12 would provide important protection for the years up to and around the age of consent."
A spokeswoman for the Department of Health said: "We cannot consider this until the JCVI puts forward a recommendation on any such matter to us." |
|
|
| Back to top |
|
 |
khyber
Joined: 16 Jan 2003
Location: Compunction Junction
|
| Posted: Sun Aug 27, 2006 9:33 pm Post subject: |
|
|
wow.
Now that is a terribly misleading title.
The vaccination is for a STD |
|
| Back to top |
|
|
dogshed
Joined: 28 Apr 2006
|
| Posted: Sun Aug 27, 2006 10:45 pm Post subject: |
|
|
| Remove all the guard rails. My kid's a good driver and won't need them. |
|
| Back to top |
|
|
Octavius Hite
Joined: 28 Jan 2004
Location: Househunting, looking for a new bunker from which to convert the world to homosexuality.
|
| Posted: Sun Aug 27, 2006 10:53 pm Post subject: |
|
|
| Except that something 90% of all cases of cervical cancer are caused by HPV so its as close to a cancer vaccine as we will probably ever get. I can live with the rebranding, its also meant to prevent religious wingnuts from turning this woman's health issue into a debate over sex. |
|
| Back to top |
|
|
matthews_world
Joined: 15 Feb 2003
|
| Posted: Sun Aug 27, 2006 10:53 pm Post subject: |
|
|
| khyber wrote: |
wow.
Now that is a terribly misleading title.
The vaccination is for a STD |
Unfortunately you don't follow the news. This AIDS drug could cure/prevent cancer, not an STD. Groundbreaking stuff.
AIDS Drug May Fight Cancer
British researchers find that an Abbott drug could also stop a virus that causes cancer.
August 25, 2006
Researchers at the University of Manchester have discovered that a widely used AIDS drug could help stop cervical cancer.
The drug Lopinavir, which interferes with HIV�s ability to replicate, is an oral drug made by Abbott Laboratories. But the U.K.-based researchers have found the drug can also kill cervical cancer cells that have been infected by the human papilloma virus, or HPV for short.
HPV is one of the most common sexually transmitted infections in the world, and it also causes the vast majority of cervical cancers.
Their findings are set to appear in the September issue of the journal Anti-Viral Therapy.
Lopinavir is already available as a liquid formulation, and researchers said that by developing a topical treatment to apply directly to the cervix it may work, avoiding surgery.
�It is very exciting to find such a significant new use for this HIV drug, which is already licensed and FDA-approved,� said research leader Dr. Ian Hampson.
If such a treatment could be brought to market for HPV, researchers said it could also be a real boost to women in poor countries who don�t have surgical options readily available.
But first researchers need to take their findings out of the labs.
�We are currently exploring the means of delivering this drug directly to the affected tissue. We would then move to a clinical trial,� Dr. Hampson said.
About 6.2 million Americans become infected with genital HPV at some time in their lives, according to the Centers for Disease Control and Prevention. On average, there are 9,710 new cases of cervical cancer and 3,700 deaths attributed to the disease in the country each year.
Worldwide, cervical cancer is the second most common cancer in women and is believed to cause 233,000 deaths each year.
HPV Breakthroughs
The biggest breakthrough to stop cervical cancer came in June when Merck & Co. won U.S. federal approval to bring an HPV vaccine to market (see Merck�s Cervical Vaccine OK�d).
The move put Merck on the road to starting what is expected to become a $4-billion industry, according to research group Windhover Information.
Also vying to bring an HPV vaccine to market is Pharmaceutical giant GlaxoSmithKline.
But the vaccines will not be able to stop all strains of the HPV virus, nor will all women be vaccinated, which is why the University of Manchester researchers think that having better treatments is still necessary.
http://www.redherring.com/article.aspx?a=18184 |
|
| Back to top |
|
|
|
|
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum
|
|
FAQ
Search
Memberlist
Usergroups
Register
Profile
Log in to check your private messages
Log in
